Alien complex ship lost on Earth

() Xiao Chuan has the cheek to ask book friends for collection and recommendation again.

-----------

"Next, this lady." Chen Qiuyu pointed to a blonde European lady.

"Ms. Chen, I'm a reporter from The Times. The price of your company's 'probiotics' is so high, which is unfair to most cancer patients. What do you think of this problem?"

"According to our knowledge, the cost of treating terminal illnesses including cancer has been high all over the world. For example, the total cost of liver replacement surgery for liver cancer in China, including early treatment and late anti-rejection, will not Less than 100 million yuan. Moreover, the longest survival period of patients who have undergone liver replacement surgery is no more than 5 years.

If the treatment of liver cancer with "prebiotics" and surgical liver replacement for liver cancer coexist, which treatment method do you think patients will adopt?

The overall cost of the same operation in developed countries in the world is more than 50 US dollars. If these two treatment methods exist, do you think they will adopt liver replacement surgery in order to save 50 US dollars?

This is one of the basis for us to formulate the price of 'prebiotics', that is, the cost of treatment is basically the same as the current treatment of the same disease.

Second, the company determines the sales price based on the production cost of 'probiotics'.All the journalists here have a certain understanding of the elements of pricing, and research costs will take a certain proportion of it.

Third, we deeply feel that the company's production capacity cannot meet the needs of cancer patients in Huaguo and even in the world.In order to increase the company's production capacity as soon as possible, we also need to raise a large amount of funds, continuously expand production capacity to meet the growing needs of cancer patients, and do our best to eliminate cancer worldwide.

Cancer patients who received 'prebiotic' treatment in advance are the biggest beneficiaries. While the company meets their needs, they also contribute their strength to the company's development and growth.

The reporters in the venue were speechless for a while, and there was such a domineering thing.You need to continuously expand production capacity, and patients must continue to provide you with funds. If you don’t provide it, it’s not enough. It’s really a robber than a robber.

The reporters secretly compared the actions of some monopoly industries with Xingkong Pharmaceuticals. It is true that no other industry can have such an irreplaceable demand that is still determined to win.

For example, without Microsoft, I can use software from other companies.Even if there are no other software companies, I can always do without a computer.

But it is really impossible for cancer patients without "prebiotics".This is the reason why "Xing Kong Pharmaceutical" dares to blackmail the world openly, and the blackmailed can only accept it willingly.

Next, a Japanese reporter asked: "Miss Chen, I am Kojiro Kojiro, a daily news reporter from Japan, and you know that cancer patients in the world account for about 1.651% of the global population, that is to say, about every 59 people. One person suffers from cancer, and there are more than 1 billion people in the world, and cancer patients exceed 60 million.

Moreover, the survival period after cancer detection is very short. In order to save the lives of tens of thousands of cancer patients, will your company consider disclosing the manufacturing technology and process of "probiotics" to the public so that more capable people Enterprises participate in the production of 'prebiotics' to meet the needs of cancer patients in the world to the greatest extent. "

The reporters in the audience all looked at this Japanese reporter with the eyes of a fool. It is not scary to be an idiot alone, what is scary is this kind of idiot who has become a reporter.

The meeting place was full of noise, and the sound of reprimanding the Japanese reporter filled the entire meeting place. The reporters present generally believed that this kind of grandstanding, high-sounding, and malicious question could only be raised by reporters from a rogue country like the Wa country.

This Japanese reporter was complacent. He felt that this question not only made him stand out, but also dug a big hole for Xingkong Pharmaceutical, which made Xingkong Pharmaceutical sink in the moral vortex.

"The reporter from the Japanese country is, I am moved by your sentiment of praying for the people of the world, and I think entrepreneurs and managers all over the Japanese country will also be moved by your noble character.

I hope you can go back to the country and appeal to the big companies in Japan, such as Mitsubishi Heavy Industries, Mitsui Heavy Industries, Sony, etc., to let them disclose all their proprietary technologies and production processes to the world, so that the world's scientific and technological development can be ri crescent moon To create more and better products to meet the needs of the people of the world and benefit the people of the world.

The company will also actively respond to the initiative of Japanese companies and companies from all over the world to disclose our technology and production process. You can rest assured that the company will never break its promise. "

Ms. Chen Qiuyu's words made Xiao Quan Erlang turn pale.

Ms. Chen Qiuyu continued: "Xing Kong Pharmaceutical is just a small company with fixed assets of only US$1000 million.

But our biggest advantage is that we have the most dedicated scientific researchers, in order to better display their ingenuity and develop more and better medicines to relieve the suffering of various patients in the world.

Our company will provide them with more excellent and advanced test conditions, which requires us to increase investment in scientific research.

Here, I can disclose a piece of news to the reporters in advance. The company’s other specific drug for kidney disease, "Shenkang", is about to enter the clinical trial stage. The injury caused by the rupture of the renal tubule wall can make the glomerular cells recover their function rapidly.

'Shenkang', a high-tech biological gene therapy drug, can completely recover patients with renal failure and renal necrosis within eight hours after injection.It avoids the pain of kidney transplantation for patients with severe kidney disease and the disadvantages of short survival after kidney transplantation, and enables patients to have a healthy kidney completely.As long as kidney disease patients have no other serious complications, the cure rate of 'Shen Kang' is 100%. "

The reporters in the audience were boiling again. The experts from the World Health Organization and the China Food and Drug Administration sitting in the first row couldn't sit still, and began to whisper to each other to exchange the information they got from the news released by Chen Qiuyu. .

One of the doctors from a famous German medical research institution stood up and said: "Ms. Chen, today is not April Fool's Day. I believe that Ms. Chen's announcement was approved by Chairman Chen Ning, but I still want to ask, is this Is it true? It's unbelievable."

Chen Qiuyu said to the German expert: "Dr. Felix, the application report and attachments of the phase 1 clinical trial of 'Shenkang' will be submitted to the China National Medical Products Administration in the near future.

The company sincerely invites Dr. Felix and the experts from the World Health Organization and other members of the assessment team to participate in the clinical trial of the biological gene drug 'Shenkang' and supervise and assess it. With that, she nodded to Dr. Felix, indicating that he could sit down.